The naturally occurring antioxidant alpha-lipoic acid, or ALA, which protects cells against the toxic effects of iron overload, may help…
Articles by Margarida Maia, PhD
A committee of the European Medicines Agency (EMA) is recommending orphan drug status — a designation that aims to speed…
Broadway performers will sing show tunes at the 15th annual Pulmonary Fibrosis Foundation Broadway Belts for PFF! event, which…
The Center for Regenerative Medicine (CReM) of Boston University and Boston Medical Center will collaborate with GSK to develop…
Imaging with a tracer that homes in on scar-forming fibroblasts may help predict the progression of pulmonary fibrosis in…
Low doses of controlled-release morphine, a natural opioid derived from the opium poppy, may reduce the frequency of daytime cough…
Certain immune cells called natural killer (NK) T-cells are present at higher numbers in the lungs of people with…
The first patient has been enrolled in a Phase 3 clinical trial of nebulized Tyvaso (treprostinil) inhalation solution for…
Many people with idiopathic pulmonary fibrosis (IPF) in the U.S. are not diagnosed early enough or given treatments helping…
Treatment with mesenchymal stem cells (MSCs) bound to tiny vesicles loaded with Ofev’s active ingredient reduced lung inflammation and…